←Back to Expert Scholars
Translational Medicine / 转化医学Emerging Lung Targets
Collin Blakely
MD, PhD
🏢University of California San Francisco🌐USA
Associate Professor of Medicine
38
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Collin Blakely is a physician-scientist at UCSF studying mechanisms of EGFR TKI resistance. His laboratory develops combination strategies targeting bypass pathways including MET and HER3. He leads investigator-initiated trials evaluating rational combinations informed by his preclinical work.
Share:
🧪Research Fields 研究领域
EGFR resistance
Tumor evolution
Preclinical models
Combination targeting
Translational biomarkers
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Collin Blakely 的研究动态
Follow Collin Blakely's research updates
留下邮箱，当我们发布与 Collin Blakely（University of California San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment